用埃菲纳可纳治疗阴菌病:对不同患者群体的考虑
Aditya K Gupta1,2, Daniel Taylor2, Daniel Dennis2
1Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
Journal of fungi (Basel, Switzerland)
|December 24, 2025
概括
埃菲纳可纳10%为各种患者群体 (包括儿童和老年人) 提供了安全的局部治疗甲菌 (指甲真菌). 本综述强调了其有效性和耐受性,强调了针对指甲真菌感染的个性化治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 菌类学 菌类学是指菌类学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲状腺炎是一种普遍的指甲疾病,需要量身定制的治疗策略.
- 局部抗真菌药物,如10%的埃菲纳可纳,是桃菌病管理的安全选择.
- 对于10%的埃菲纳可纳的实际应用,需要对各种患者人口统计学进行具体考虑.
研究的目的:
- 进行对10%的埃菲纳可纳用于桃病治疗的范围审查.
- 评估10%埃菲纳可纳在不同患者群体中的疗效和耐受性.
- 确定在临床实践中使用efinaconazole 10%的特殊考虑因素.
主要方法:
- 在2025年10月进行的文献搜索.
- 搜索的数据库包括PubMed,Embase,CENTRAL和科学网络.
- 专注于详细介绍小儿科,老年人,糖尿病患者和服务不足人群中efinaconazole 10%使用的研究.
主要成果:
- 埃菲纳可纳10%在儿童和青少年中显示出比成人更高的疗效.
- 老年患者可能需要延长治疗时间和维持治疗.
- 对efinaconazole的高度敏感性10%观察到,即使在对terbinafine耐药的皮肤菌株中也是如此.
- 埃菲纳可纳10%在糖尿病患者中有效,在拉丁裔/西班牙裔患者中没有显著差异.
- 局部抗真菌溶液耐受性良好,具有局部副作用.
结论:
- 埃菲纳可纳10%是一种在各种患者群体中耐受良好且有效的局部治疗桃菌病的药物.
- 个性化治疗方法,考虑到年龄,并发病症和潜在的耐药性,至关重要.
- 解决同时出现的脚和建议使用指甲油是防止复发和确保治疗成功的重要.
相关概念视频
01:29Fungal Group Zygomycota
944
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
944
01:28Fungal Phylum Microsporidia
374
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
374
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
234
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
234
01:26Fungal Phylum Basidiomycota
813
Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
813
01:23Skin Diseases and Disorders
5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K